MAWAG
ABBV icon

Mid-American Wealth Advisory Group’s AbbVie ABBV Stock Holding History

Mid-American Wealth Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-91
Closed -$16.9K – 51
2025
Q2 		$16.9K Buy
+91
New +$16.9K 0.01% 129
2023
Q3 		– Sell
-7,434
Closed -$1M – 41
2023
Q2 		$1M Buy
+7,434
New +$1.09M 0.78% 34
2022
Q1 		$1.21M Sell
7,483
-1,272
-15% -$185K 0.95% 33
2021
Q4 		$1.19M Buy
+8,755
New +$1.03M 0.95% 30

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mid-American Wealth Advisory Group's ABBV Position: Q3 2025 in Review

Mid-American Wealth Advisory Group sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 91 shares — an estimated $16.9K sold.

Mid-American Wealth Advisory Group first reported a position in ABBV in Q4 2021 and held it in 4 quarters. The position peaked at $1.21M in Q1 2022. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Mid-American Wealth Advisory Group reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
  • Mid-American Wealth Advisory Group sold 91 AbbVie shares in Q3 2025, an estimated $16.9K.
  • Mid-American Wealth Advisory Group first reported a position in AbbVie in Q4 2021 and held it in 4 quarters.
  • Mid-American Wealth Advisory Group's AbbVie position peaked at $1.21M in Q1 2022.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Mid-American Wealth Advisory Group's 13F filing for Q3 2025, filed 20 Oct 2025.